Sort
23,748 grants matching “melanoma”
Engineered T cells for improved migration into solid tumor sites
$218,790Jordan Jacobelli · University Of Colorado Denver · R21 · FY2025 · CA
How p16 and MC1R mutations synergistically exacerbate melanoma risk.
$218,776Zalfa Abdel-Malek · University Of Cincinnati · R21 · FY2014 · CA
Mechanistic efforts of chronic alcohol on tumor metastasis and survival
$218,775Gary G Meadows · Washington State University · K05 · FY2012 · AA
Innate Immunity and Gender Differences in Melanoma
$218,750Moshe Arditi · Cedars-Sinai Medical Center · R21 · FY2017 · AI
Carbohydrate-carbohydrate interaction in cell biology
$218,750Pacific Northwest Research Institute · R01 · FY2005 · GM
Regulatory mechanisms of the MDA5-mediated antiviral interferon response
$218,750Michaela Ulrike Gack · Harvard Medical School · R21 · FY2012 · AI
PEG-Prom Mediated Theranostics for Prostate Cancer
$218,727Martin G Pomper · Johns Hopkins University · P50 · FY2015 · CA
Breast cancer Vaccine Strategies for HER2-Overexpressing and Lum. B Tumors
$218,703Jonathan Stuart Serody · Univ Of North Carolina Chapel Hill · P50 · FY2007 · CA
MOLECULAR PREDICTIVE TESTING IN OCULAR MELANOMA
$218,701James W Harbour · Washington University · R01 · FY2011 · CA
CANCER AND LEUKEMIA GROUP B
$218,694Duke University · U10 · FY2002 · CA
Dietary methionine restriction as a therapeutic strategy for metastatic melanoma
$218,679Isabelle Racine Miousse · University Of Arkansas At Fayetteville · P20 · FY2022 · GM
Telomere dysfunction and genome instability in familial melanoma
$218,588Sandy S Chang · Yale University · R21 · FY2017 · CA
Blocking ligand-dependent BMP signaling as an anti-melanoma strategy
$218,588Craig Joseph Ceol · Univ Of Massachusetts Med Sch Worcester · R21 · FY2018 · CA
Integrative genomic biomarkers for predicting response to immunotherapy in melanoma patients
$218,588Ruth Halaban · Yale University · R21 · FY2017 · CA
Armed oncolytic parvoviral vectors for modulating the tumor microenvironment
$218,588Peter Tattersall · Yale University · R21 · FY2020 · CA
Smartphone confocal microscopy for diagnosing Kaposiâs sarcoma
$218,544Dongkyun Kang · Massachusetts General Hospital · R21 · FY2015 · TW
PG545 synergizes with PARP inhibitors in ovarian cancer to disrupt DNA repair through modulation of DEK-RAD51 axis
$218,538Viji Shridhar · Mayo Clinic Rochester · R21 · FY2023 · CA
Ex vivo generation of tumor-reactive T cells for adoptive cell transfer using an immune enhanced, patient derived tumor organoid-on-a-chip (iTOC)
$218,513Aleksander Skardal · Ohio State University · R21 · FY2022 · CA
An Intelligent Melanoma Diagnostic Training System
$218,452University Of Pittsburgh At Pittsburgh · R25 · FY2004 · CA
Project 2 - Joshua Hood, PhD
$218,400Joshua L. Hood · University Of Louisville · P20 · FY2021 · GM
TRANSCRIPTION FACTOR AP2 IN METASTASIS OF MELANOMA
$218,370University Of Texas Md Anderson Can Ctr · R01 · FY2002 · CA
Engineering Cytolytic Effectors to Eliminate Virus-Infected and Cancer Cells
$218,309Adam Chervin · Immuven, Inc. · R41 · FY2014 · CA
(PQB2) Identification of Tumor-Derived Activators of Anti-Cancer Immune Responses
$218,296John B Sunwoo · Stanford University · R21 · FY2014 · CA
A novel attachment mechanism for Burkholderia cepacia complex
$218,250Tung T Hoang · University Of Hawaii At Manoa · R21 · FY2023 · AI
INVASIVE BEHAVIOR OF TUMOR CELLS PRODUCING COLLAGENASE
$218,189Dartmouth College · R01 · FY2002 · CA